AB 2300 (Wilson, D-Suisun City)

AB 2300 would phase out the manufacture, sale, or distribution of IV bags and IV tubing made with intentionally added Di (2-ethylhexyl) phthalate (DEHP). Beginning Jan. 1, 2030, the manufacture, sale, or distribution of IV bags with intentionally added DEPH would be prohibited. Manufacturers would be able to extend this deadline to 2032 if they meet public disclosure criteria. Beginning Jan. 1, 2035, this prohibition would be extended to all IV tubing. Certain blood kits, bags, and tubing would be exempted from this prohibition.